Data Collection and Professional Simulated Use Study to Develop an Embryo Quality AI Model
Launched by FAIRTILITY · Jun 4, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to improve an artificial intelligence (AI) tool that helps assess the quality of embryos, which are crucial in fertility treatments like in vitro fertilization (IVF). The goal is to use high-quality images and data from real patients to train and validate this AI model, ensuring it works well in real-life situations. The study also aims to make sure that healthcare professionals can easily and correctly use the AI applications.
If you're a woman aged 18 or older and have undergone egg retrieval as part of standard egg-freezing or IVF treatments, you may be eligible to participate. Participants will need to provide images of their eggs or embryos, which are kept in a special incubator connected to the AI system. Those who have no available eggs, whether their own or from a donor, will not be eligible. By joining this study, you will be contributing to the development of technology that could help many women facing fertility challenges in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Images and data of eggs or embryos available from egg retrievals by women undergoing standard egg-freezing or IVF treatments, using their own eggs or donor eggs.
- • 2. Women at least 18 years of age.
- • 3. Embryos or eggs cultured in a time-lapse incubator connected to the AI Embryo Viewer.
- Exclusion Criteria:
- • Women with no available own or donor eggs.
About Fairtility
Fairtility is an innovative biotechnology company dedicated to enhancing reproductive health through advanced artificial intelligence solutions. By leveraging cutting-edge technology, Fairtility aims to optimize fertility treatment outcomes, providing healthcare professionals and patients with data-driven insights that improve decision-making processes in assisted reproductive technologies. Committed to clinical excellence and patient-centered care, Fairtility collaborates with leading fertility clinics and research institutions to advance the science of reproduction, ensuring that each cycle is as effective and personalized as possible.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stamford, Connecticut, United States
Patients applied
Trial Officials
Klaus Wiemer, PhD
Study Chair
Fairtility
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported